Delivery Order SPE2DB20D1100-SPE2DB24FA2K2

Award Date 2/14/24
Potential Completion Date 2/15/24
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,563,679,754 tablets of 36 mg Methylphenidate ER. The contract has a potential value of $1,288.15 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, will deliver the medications to support military treatment programs and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,563,823,428 units of the drug Methylphenidate ER 54 mg tablets. The order has a potential value of $1,596.41 and a completion date of March 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, valued up to $999,999,999.00 with a performance...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 4,563,636,784 units of Methylphenidate ER 54 mg tablets. The contract has a potential value of $1,582.62 and a completion date of February 13, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to...
This federal contract award is for the delivery of 4,564,659,978 tablets of methylphenidate extended-release (10 mg) to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The fixed-price, firm-fixed delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for a total ceiling value of $2,153.22. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,186,397 tablets of Methylphenidate ER 27 mg. The contract has a ceiling value of $1,693.74 and a period of performance through April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of...
This is a $1,135.20 firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,404,218 units of 27 mg methylphenidate extended-release tablets. The order has an ultimate completion date of August 12, 2024. AmerisourceBergen is the prime contractor for this award, which is not set-aside. The order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of 4,564,327,549 methylphenidate extended-release 27 mg tablets in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,356.92 and a completion date of April 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to supply 4,563,666,767 tablets of Methylphenidate ER 27 mg. The $3,884.34 contract has a completion date of February 15, 2024 and was awarded on February 14, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp that has a potential...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of 4,565,331,287 units of Methylphenidate Extended-Release 54 mg tablets. The contract has a firm fixed price of $2,004.23 and an ultimate completion date of August 5, 2024. This is a delivery order contract without any set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will provide these medications to support military treatment...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,578.87 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,426,625 doses of methylphenidate extended-release 36mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical and medical supplies to...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA2K2
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,563,663,573 tablets of methylphenidate extended-release 18 mg. The contract has a total potential value of $7,474.55 and a completion date of February 15, 2024. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.

Generated 5/19/24, 12:31 AM